TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Complete Response Duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of recurrences post completion of curative therapies
Endpoint domain: Mortality/survival
Primary endpoint: Recruitment Rates at Baseline
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Enrollment Rates at Baseline
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Retention Rates at Post-Intervention (6 weeks)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Variation in 18F-NaF uptake in plaques
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Composite of Death, Myocardial Infarction and Target Vessel Revascularization
Endpoint domain: Mortality/survival
Primary endpoint: Change From Baseline in Mean ADAS-Cog Total Score at W24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change From Baseline in Mean CIBIC+ Global Functioning Total Score at W24
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of Patients With Negative HDV RNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain postoperative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with hypoglycaemic episodes
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of hospitalization for heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical efficacy at the RP2D
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion rate of small bowel endoscopy examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Duration of time taken for camera capsule to enter duodenum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reduction in the Migraine Disability Test (MIDAS) score
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Reduction in the Headache Impact Test (HIT-6) score
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Weight and linear growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sport or recreational injury
Endpoint domain: Adverse events/effects
Primary endpoint: Colonization with S. pneumoniae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean Percent Change in Peak Esophageal Eosinophil Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean Change in Physician's Esophageal Eosinophil Global Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum-tolerated dose of 90Y-DOTA-tyr3-Octreotide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: short term and long term safety
Endpoint domain: Adverse events/effects
Primary endpoint: Knowledge of Type 1 Diabetes Disease
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Diabetes Management Questionnaire (DMQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in WOMAC
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time to functional recovery postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with pancreatic adenocarcinoma who achieve administration of adjuvant chemotherapy at 8 weeks postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Composite Outcome of Myocardial Injury After Non-cardiac Surgery, Non-fatal Cardiac Arrest, and All-cause Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Indirect respiratory quotient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Vaginal length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Counts and Percentages of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Neurocognitive sequelae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Maximum tolerated dose (MTD) of the drug combination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of adverse events per Common Terminology Criteria for Adverse Events (CTCAE) version 4.0
Endpoint domain: Adverse events/effects
Primary endpoint: Burnout levels in Family Medicine resident physicians
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Determining benign thyroid nodules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Determining malignant thyroid nodules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: fasting low-density lipoprotein cholesterol (LDL-C) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Social-emotional and behavioural problems
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Participants Who Had One or More Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Had One or More Serious Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Had One or More Adverse Drug Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Had One or More Serious Adverse Drug Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Who Responded in Platelet Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cell-associated HIV RNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Medication Adherence Rating Scale (MARS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: World Health Organization Quality of Life Instrument Short Form (WHOQOLBREF-TR)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Objective response rate (ORR) per modified Prostate Cancer Working Group 3 (PCWG3) criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in perioperative Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: corneal nerve fiber length (CNFL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: corneal nerve fiber density (CNFD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: average corneal nerve single fiber length (CNSFL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Oocytes MII retrieved per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Intra-operative Surgical Visibility - Boezaart Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Intra-operative Surgical Visibility - Wormald Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of hours until first bowel movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Grade II and III toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Non-nutritive sucking habits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose of propofol required to maintain BIS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurocognitive changes
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in EQ-5D-3L
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Visual Analogue Scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Flow Mediated Dilation (FMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Composite outcome of death, myocardial infarction, stroke, repeat revascularisation, and BARC defined bleeding
Endpoint domain: Mortality/survival
Primary endpoint: Prolongation of cardiac QT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: UPDRS- Improvement in Activities of Daily Living
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UPDRS- Improvement in motor Examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: % Positive Rapid Antigen Strep Tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: exercise time with high flow nasal cannula
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: exercise time with nasal cannula
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal visual analogue scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Liver function test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness using Goodman and Baron Assessment scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Treatment Failure
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of patients reaching blood pressure goal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: maintenance of reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCt - Cumulative Area Under the Plasma Concentration Time Curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time Curve Extrapolated to Infinity (AUC∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in common complications of preterm birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subject response to W0027 regimens
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: in-hospital heart failure-related complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline in Rey Auditory Verbal Learning Test scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline in Digit Span Task scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline in Colour Trails Test scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline in Block Design Test scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline fMRI scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease Activity Score (DAS 28 score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of amplitude observed in thromboelastography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Probability of fistula closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of eyes with reduced macular thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Standardized Uptake Value (SUV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of episodes of NLC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of rehospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Appetite and satiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Acute treatment related toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: pain and function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of Participants With Stent Thrombosis: Late
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline in Pre-Dose Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Mean Corneal Staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Slit-Lamp Findings: Eye Structure: Cornea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Actigraph and self report questionnaires
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Levels of serum alanine aminotransferase (ALT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Overall Survival at One Year
Endpoint domain: Mortality/survival
Primary endpoint: Cortical location of function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: volume of prenatal visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: deliveries
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Serum HBV DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Aspartate aminotransferase (AST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Change of Alanine aminotransferase (ALT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Change of γ-glutamyltransferase (γ-GT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Percentage of Patients Classified as Treatment Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Narcotic Use During Hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Overall efficacy evaluated by the caregiver/patient
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall haemostatic evaluation by the surgeon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Successful discontinuation of benzodiazepines
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of task saturation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: amount and type of opioid consumption at 24 hours
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of responders moderately or markedly improved
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Participants With Clinically Significant Findings in Physical Examinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetic (PK) Analysis of Inhaled GB002: Maximum Concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective Response Rate (ORR) in EEC or EOC Patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Objective Response Rate (ORR) in Carcinosarcoma (MMMT) Patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Undetectable HCV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Pulsatility index of fetal ductus arteriosus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline in Quality of Life (QoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: D-Dimer content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of Participants on LCZ696 200 mg Bid at Month 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of QR-333 application
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence and severity of (S)AEs
Endpoint domain: Adverse events/effects
Primary endpoint: COVID-19 hospitalisation
Endpoint domain: Mortality/survival
Primary endpoint: COVID-19 intensive care
Endpoint domain: Mortality/survival
Primary endpoint: COVID-19 fatal outcome
Endpoint domain: Mortality/survival
Primary endpoint: worse motor symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: worse cognitive symptoms
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: worse sleep symptoms
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Percentage enrolment and attendance to rehabilitation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Responsiveness to rhG-CSF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of Anastomotic Leaks
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of fat thickness in the upper arms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ADHD Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impression - Improvement Scale (CGI-I)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of blood donors with a diagnosis of cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of Thrombotic events among enrolled cancer patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in frailty
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rapid Upper Limb Assessment (RULA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: counts of streptococcus mutans
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Subjective Cure of Urinary Incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Effectiveness of identification of prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Clitoral artery peak systolic velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clitoral artery acceleration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percent of Toenails Attaining 3 mm or More of Clear Nail Growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electroencephalography (EEG) measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Knowledge and understanding of educational materials
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proportion of patients with hormone deficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Percentage of Critically Ill Patients Achieving Feasibility Criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of patients completing remote rehab program
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Neurodevelopmental scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Patients Achieving Principal Active Functional Goal
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of patients downstaged to resectability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Success based on overall POP-Q score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in low back pain related disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Patient peri-operative temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Memory Testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in delirium severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant satisfaction reporting scale (PSRS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: cTn-T levels immediately after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CK-MB levels immediately after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hemostasis tests results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-term complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kinematics Translations During Deep Knee Bend (DKB) Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Kinematics During Deep Knee Bend (DKB) Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Kinematics Translations During Squat to Stand (S2S) Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Kinematics During Squat to Stand (S2S) Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Kinematics Translations During Ramp up Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Prevalence of Heavy Menstrual Bleeding (HMB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes